4
Changes in Ownership
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001946043-22-000003
Options or other derivatives
- Chief Commercial Officer acquired 3,000,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kirkov Kirko Chief Commercial Officer | 2022-09-06 | Grant or award · Options | +3,000,000 | $0.04 | $105,000 | 3,000,000 | D: show line 1 in the form |
Loading xslF345X03/primary_doc.xml…